The Gut Microbiome: Where to look for Biomarkers

Similar documents
Companion Diagnostics in Autoimmune Disorders: Improving Outcomes Through Personalized Medicine

THE HUMAN MICROBIOME: RECENT DISCOVERIES AND APPLICATIONS TO MEDICINE

Customized Phage Therapies To Eradicate Harmful Bacteria In Chronic Diseases. Europe Microbiome Congress London, 14 Nov., 2018

Human Microbiome Project: First Map of the World Within Us. Hsin-Jung Joyce Wu "Microbiota and man: the story about us

OMNIgene GUT stabilizes the microbiome profile at ambient temperature for 60 days and during transport

Promise and Pitfalls of MicrobiomeModulating Methods for Inflammatory

Diagnostic Accuracy of Two Faecal Calprotectin Immunoassays

SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K CURRENT REPORT

Lecture 8: Predicting and analyzing metagenomic composition from 16S survey data

CONSIDERING THE MICROBIOME AS PART OF FUTURE MEDICINE AND NUTRITION STRATEGIES: Challenges and proposed answers

Rebiotix: Business, Regulatory and Clinical Challenges in Commercializing a Microbiota Based Drug. May 2016

Topic: Targeted immune intervention for treatment of nonresponse

Lecture 8: Predicting metagenomic composition from 16S survey data

Functional profiling with HUMAnN2

Microbiota and What the Clinical Gastroenterologist Needs to Know

Shantelle Claassen-Weitz Division of Medical Microbiology Department of Pathology

Functional profiling of metagenomic short reads: How complex are complex microbial communities?

BIOLOGIC AND BIOSIMILAR MEDICATIONS

Biologics in IBD: Optimizing Therapies and Emerging Agents

Future Directions in IBD: Treatments & Approaches

Andrew Nesbitt, PhD. Disclaimer 10/10/2014. Determining the Immunogenicity of Biologics: a Tricky Problem. Employee of UCB ן

Mini-Symposium MICROBIOTA. Free. Meet the speaker. 14. November :30 19:00 Bohnenkamp Haus. Everyone welcome. Sponsored by:

The role of mucus associated bacteria in Inflammatory Bowel Disease

UBS 2016 Health Care Conference May 24, 2016

METAGENOMICS. Aina Maria Mas Calafell Genomics

Next G eneration Generation Microbial Microbial Genomics : The H uman Human Microbiome P roject Project George Weinstock

BL-7040: Oligonucleotide for Inflammatory Bowel Disease

FRAUNHOFER INSTITUTE FOR INTERFACIAL ENGINEERING AND BIOTECHNOLOGY IGB NEXT-GENERATION SEQUENCING. From wet lab to dry lab complete sample analysis

Introducing QIAseq. Accelerate your NGS performance through Sample to Insight solutions. Sample to Insight

The Human Microbiome Project : Implications for Probiotics

March Company Introduction. Microbiome R&D and Business Collaboration Forum: Europe Myriam Golembo, VP Development

Next Generation Sequencing

John F. Kokai-Kun Digestive Disease Week Chicago, IL May 9, 2017

UK Biobank Past, Present, and Future

BIOLOGIC MEDICATIONS IN THE TREATMENT OF IBD. crohnsandcolitis.ca

Carl Woese. Used 16S rrna to developed a method to Identify any bacterium, and discovered a novel domain of life

Carl Woese. Used 16S rrna to develop a method to Identify any bacterium, and discovered a novel domain of life

Microbiomics I August 24th, Introduction. Robert Kraaij, PhD Erasmus MC, Internal Medicine

Assembly Biosciences Jefferies 2015 Microbiome Summit. December 16, 2015

BATTLING BUGS: INROADS IN INFECTIOUS DISEASES

Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development)

Metagenomics Computational Genomics

An introduction into 16S rrna gene sequencing analysis. Stefan Boers

May Microbiome Modulation. Assaf Oron, CBO Biomed Conference Tel Aviv, May 2017

FREQUENTLY ASKED QUESTIONS

Precision Medicine in Sepsis

hamilton firefly nimbus 96

Jan Company Introduction. Microbiome Drug Development Europe Assaf Oron, CBO

Metagenomics in Medicine Towards Disease early Diagnosis and Personalized Treatment

Emerging Medical Therapies in Inflammatory Bowel Disease

SYN-004 (ribaxamase) prevents New Onset Clostridium difficile Infection by Protecting the Integrity Gut Microbiome in a Phase 2b Study

Nature Biotechnology: doi: /nbt Supplementary Figure 1. MBQC base beta diversity, major protocol variables, and taxonomic profiles.

Metagenomics of the Human Intestinal Tract

The. Conception of. GCC- Specific. Chimeric Antigen Receptors

Biomarkers for Delirium

Engage with us on Twitter: #Molecule2Miracle

Applications of Next Generation Sequencing in Metagenomics Studies

SYMPOSIUM Student Journal of Science & Math. Volume 2 Issue 1

The Future Role of Biosimilars: An Unknown Frontier in IBD Treatment

Drug Development in Inflammatory Bowel Disease: The FDA Perspective

Jianguo (Jeff) Xia, Assistant Professor McGill University, Quebec Canada June 26, 2017

Building DNA Libraries to Explore the Combinatorial Design Space. Dr. Yifan Li Senior Scientist GenScript USA Inc.

Biotechnology Laboratory II, BIOL 5504 Spring 2018 Policies and Syllabus

Quantifying Your Superorganism Body Using Big Data Supercomputing

Microbiota: Agents for Health and Disease Dr. B. Brett Finlay

INTELLIGENT ANTIBODY DISCOVERY FROM HUMANS AND OTHER ANIMALS. Guy Cavet

Genetics and Inflammatory Bowel Disease

Microbial Community Assembly and Dynamics:.from AMD biofilms to colonization of the premature infant gut

FDA Regulation of Companion Diagnostics

Building a deep immuno-oncology portfolio in less than a year. David Johnson, PhD PEGS Spring 2018

The Human Microbiome: A New Paradigm? John Huss Department of Philosophy The University of Akron

Session 3 Lecture 1 Dynamics of the GIT Microbiome: Microbial Darwinism

Factors Affecting the Composition of the Laboratory Mouse Microbiome. Aaron C. Ericsson, DVM, PhD HESI Microbiome Workshop June 26, 2018

Etienne Ruppé AP HP, Hôpital Bichat Claude Bernard UMR 1137 IAME

PROFESSIONAL ETHICS, LEADERSHIP AND INTEGRITY: WHAT DOES IT MATTER HOW OUR RESEARCH IS USED? Suzanne Hendrich, PhD University Professor FSHN

Sequencing the Astronaut Microbiome. Hernán Lorenzi PhD. July 17 th, 2014 The J. Craig Venter Institute

Interplay of Cells involved in Therapeutic Agent Immunogenicity. Robert G. Hamilton, Ph.D., D.ABMLI Professor of Medicine and Pathology

Human Microbiome Project: A Community Resource. Lita M. Proctor, Ph.D. Coordinator, Human Microbiome Project NHGRI/NIH

Immunity for Life TM. Sven Rohmann VP Business Development

Quick-DNA. DNA from any Sample

Clarity Genomics. Company Profile

Course Agenda. Day One

Accessible answers. Targeted sequencing: accelerating and amplifying answers for oncology research

REFERENCE CODE GDHC342DFR PUBLICAT ION DATE FEBRUARY 2014 ENTYVIO (ULCERATIVE COLITIS) - FORECAST AND MARKET ANALYSIS TO 2022

2111: ALL Post-HCT. Add/ Remove/ Modify. Manual Section. Date. Description. Comprehensive Disease- Specific Manuals

AIT - Austrian Institute of Technology

Nanotechnology: A Brief History and Its Convergence with Medicine. Weston Daniel, PhD Director of Program Management

Chapter 17: Immunization & Immune Testing. 1. Immunization 2. Diagnostic Immunology

1. Immunization. What is Immunization? 12/9/2016. Chapter 17: Immunization & Immune Testing. 1. Immunization 2. Diagnostic Immunology

CBC Data Therapy. Metagenomics Discussion

Conducting Microbiome study, a How to guide

Challenges in receptor occupancy determination assays by flow cytometry in drug development

REFERENCE CODE GDHC347DFR PUBLICAT ION DATE FEBRUARY 2014 SIMPONI (ULCERATIVE COLITIS) - FORECAST AND MARKET ANALYSIS TO 2022

Microbiota Cutaneo, Salute e Bellezza

Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development) READ ONLINE

Effects of Pharmaceutical Exposures Ian Wilson

DNA Sequencing. Happiness Kumburu BSU- workshop Nov, 2016

Next Generation Sequencing of HLA: Challenges and Opportunities in the era of Precision Medicine. Dr. Paul Keown, 2016

Discovery of Bacterial Effectors in the Human Microbiome and Isolation of a GPCR G2A/GPR132 Agonist

Transcription:

The Gut Microbiome: Where to look for Biomarkers Microscopic Image showing Skin cells at 20x magnification Carrie Brodmerkel, PhD Head, Immunology Biomarkers June 25, 2018

Agenda Where you can measure and what you can measure Considerations in selecting where and what to measure Beyond the standard Watchouts when interpreting microbiome data Population vs individual 2

Gut Microbes as the Source of Biomarkers Mucosal Biopsy Colonic Brushing Rectal Swab Urine Stool 3

Standard Molecular Methods for Microbiome https://www.nap.edu/read/24960/chapter/6#57 4

Diversity is commonly used to assess health The microbiome of uncontacted Amerindians Clemente et al. Sci. Adv. 2015;1:e1500183 17 April 2015 5

Alpha Diversity Response to Anti-TNF therapy in Ulcerative Colitis: Remitters More Diverse Than Nonremitters Diversity associated with remission Remitters more diverse compared to nonremitters posttreatment Does not appear to be specific to golimumab UC has less evidence of dysbiosis then CD Remitter Nonremitter Week 0 Week 6 400 mg 200 mg placebo 400 mg 200 mg placebo

7

Host as the Source of Biomarkers Mucosal Biopsy Stool Serum/Plasma Peripheral Blood https://www.immunopaedia.org.za/immunology/basics/5-overview-of-t-cell-subsets/ 8

The gut microbiome: host vs microbe influence on the immune system, disease and response to treatment 9

Beyond the standard: Better to Assess Sequence and Function? Knowing what bugs make can lead to better understanding of microbe-host and microbe- microbe interactions Closely related bugs by sequence may produce different small molecules leading to different interpretations of the microbial diversity of a subject than use of taxonomic classification alone Cell 158, 1402 1414 10

Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease: Use of IgA-SEQ Cell. 2014 August 28; 158(5): 1000 11

Microbial Antibodies Front Med (Lausanne). 2018 May 23;5:153 Microbial antibodies detected in various immune diseases Only limited number of antibodies measured (ASCA, OmpC, etc.) Opportunity exists to expand J Clin Immunol. 2009 March ; 29(2): 190 12

Biomarkers: Population vs Individual 13

Going from Population to Individuals Baseline microbiome predicting week 6 clinical readout post Ustekinumab (anti-p40 mab) in mod/severe CD Baseline microbiome predicting engraftment post FMT in rcdi subjects Wk6 clinical response Wk6 clinical remission Doherty et al mbio 2018 Smillie et al Cell Host & Microb 2018 14

Are we ready? Methods are continually evolving and current understanding may shift based on improvements Extraction methods Absolute vs relative abundance of microbes Sequencing depth and tools to characterize microbes 15

Why DNA extraction protocol matters DNA quality (line=1.8kb) DNA quantity 21 DNA extraction protocols evaluated on same fecal samples (11 countries/3 continents) Cutoff drawn at >500ng of DNA with <25% fragmentation Compared with library prep, sample storage, biologic variation within sample and within subject over time DNA extraction had largest effect on outcome of metagenomic analysis Costea et al Nature Biotechnology Oct 2017 16

Why DNA extraction protocol matters Species Function Abundance Relative effect size of variation tested: Using Spearman distance to rank abundances found comparable species rankings between protocols Using Euclidean distance to assess abundance there was high variability between protocols Inter-individual variation as expected is largest source of variation Costea et al Nature Biotechnology 2017 17

Relative Abundance vs Absolute Abundance Relative composition doesn t allow for understanding of absolute abundance considering the variability across specimens Vastly different interpretations about diversity can be made depending on use of relative vs absolute abundance

Relative vs Absolute Abundances Yield Different Conclusions Same stool samples from mice treated with vancomycin High-Dose Vancomycin Low-Dose Vancomycin High-Dose Vancomycin Low-Dose Vancomycin Eduardo Contijoch Jeremiah Faith Ichan School of Medicine Mt Sinai 19

How do you define a species or strain in a complex environment? In human stool a single species may be <0.1% of reads Dana C, Thomas 20

Sequencing depth and tool matter Downsampling of deep seq environmental sample Depth of sequencing can significantly change the results of a metagenomic study, depending on the tool used Marker-based tools identified far more species as depth of sequencing increased Essential to standardize sequencing depth and analytical tool to compare between similar studies McIntyre et al biorxiv 2017 21

Recent data from HMP Still more to learn # of gene families has not yet leveled off J Lloyd-Price et al. Nature 1 6 (2017) doi:10.1038/nature23889

Key considerations What question are you trying to answer What sample Microbial and/or Host Site of action Static vs Functional What methodology Is there consensus on how to analyze and interpret the data? What biases might be inherent in the data How can the data be interpreted Population vs Individual 23

THANK YOU Janssen Ling-Yang Hao Lani San Mateo Ichan School of Medicine Eduardo Contijoch Jeremiah Faith 24